Bonini, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 1.122
AS - Asia 911
EU - Europa 771
SA - Sud America 352
AF - Africa 45
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.206
Nazione #
US - Stati Uniti d'America 1.079
SG - Singapore 451
BR - Brasile 300
IT - Italia 213
CN - Cina 174
SE - Svezia 146
VN - Vietnam 93
FR - Francia 63
IE - Irlanda 62
DE - Germania 57
ID - Indonesia 49
RU - Federazione Russa 49
GB - Regno Unito 39
FI - Finlandia 34
HK - Hong Kong 26
NL - Olanda 25
BD - Bangladesh 23
AR - Argentina 22
MX - Messico 19
IN - India 17
AT - Austria 16
IQ - Iraq 15
ZA - Sudafrica 14
CA - Canada 11
PL - Polonia 11
BE - Belgio 10
EC - Ecuador 9
TR - Turchia 9
ES - Italia 8
MA - Marocco 8
UA - Ucraina 8
SA - Arabia Saudita 7
IR - Iran 6
KR - Corea 6
RS - Serbia 6
VE - Venezuela 6
AZ - Azerbaigian 5
PK - Pakistan 5
AO - Angola 4
CL - Cile 4
CO - Colombia 4
DZ - Algeria 4
HN - Honduras 4
CZ - Repubblica Ceca 3
GR - Grecia 3
JO - Giordania 3
JP - Giappone 3
LT - Lituania 3
NP - Nepal 3
PY - Paraguay 3
RO - Romania 3
TN - Tunisia 3
AU - Australia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DM - Dominica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
HR - Croazia 2
KZ - Kazakistan 2
MD - Moldavia 2
PE - Perù 2
PH - Filippine 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CU - Cuba 1
DK - Danimarca 1
GA - Gabon 1
GH - Ghana 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
PW - Palau 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.206
Città #
Chandler 300
Singapore 170
Ashburn 104
Dublin 61
Beijing 54
Jakarta 43
Milan 39
Marseille 36
Boston 35
Princeton 35
New York 33
Ho Chi Minh City 31
Dearborn 26
Wilmington 26
Rome 24
São Paulo 24
Moscow 23
Helsinki 22
Hong Kong 22
San Mateo 21
Los Angeles 19
Boardman 17
Hanoi 16
Nanjing 16
Hefei 15
Dallas 14
Rio de Janeiro 12
Nuremberg 11
Ann Arbor 10
Brussels 10
London 10
Redwood City 10
Belo Horizonte 9
Bremen 9
Johannesburg 9
Lappeenranta 9
Brooklyn 8
Fairfield 8
Changsha 7
Dhaka 7
Frankfurt am Main 7
Hebei 7
Santa Clara 7
Warsaw 7
Woodbridge 7
Bergamo 6
Florence 6
Hải Dương 6
Manaus 6
Munich 6
Norwalk 6
Seoul 6
Atlanta 5
Auburn Hills 5
Baku 5
Belgrade 5
Brasília 5
Buffalo 5
Cambridge 5
Chicago 5
Curitiba 5
Haiphong 5
Houston 5
Jiaxing 5
Lauterbourg 5
Orem 5
Redmond 5
The Dalles 5
Toronto 5
Vienna 5
Amsterdam 4
Baghdad 4
Bexley 4
Da Nang 4
Düsseldorf 4
Jeddah 4
Kent 4
Luanda 4
Mountain View 4
Nanchang 4
Piracicaba 4
Quito 4
Salvador 4
Shanghai 4
Sorocaba 4
Stockholm 4
São José do Rio Preto 4
Agrate Brianza 3
Amman 3
Augusta 3
Biên Hòa 3
Campinas 3
Casablanca 3
Collegeville 3
Florianópolis 3
Goiânia 3
Jacksonville 3
Joinville 3
Lamezia Terme 3
Leawood 3
Totale 1.629
Nome #
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)—a EAACI position paper 172
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 151
Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A "Real-Life" Observational Study in the First Year of Treatment 143
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 108
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly 106
Severe asthma: One disease and multiple definitions 106
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact 94
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 89
Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry 87
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial 85
Exercise-Induced Bronchoconstriction: Background, Prevalence, and Sport Considerations 84
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology 81
Allergy screening in a schoolchildren-based population 80
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence 79
Asthma, allergy and the olympics: A 12-year survey in elite athletes 78
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma 78
The role of mobile apps in allergic respiratory diseases: An italian multicentre survey report 77
Impact of chronic obstructive pulmonary disease on exercise ventilatory efficiency in heart failure 74
Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis 73
Effectiveness of myAirCoach: A mHealth Self-Management System in Asthma 72
Anti-muscarinic drugs as preventive treatment of exercise-induced bronchoconstriction (EIB) in children and adults 72
Research highlights from the 2018 European Respiratory Society International Congress: airway disease 71
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan - An EAACI position paper 70
Let research leave you breathless, not physical exercise! 68
Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018 67
Small Airways Disease as a Novel Target for Mepolizumab in Asthma—The SASAM Prospective Real-Life Study 66
The Impact of Telemedicine during Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic and Future Perspectives: A Systematic Review 65
Feasibility of the Allergy Questionnaire for Athletes (AQUA © ) in pediatric age 65
Minimal clinically important difference for asthma endpoints: An expert consensus report 64
Electronic health (e-Health): Emerging role in asthma 63
The role of the small airways in the pathophysiology of asthma and chronic obstructive pulmonary disease 62
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation 62
Evaluation of Allergic Diseases, Symptom Control, and Relation to Infections in a Group of Italian Elite Mountain Bikers 61
Biosimilars and drug development in allergic and immunologic diseases 60
Correlation between intrarenal arterial stiffness and exercise tolerance in systemic sclerosis patients without renal and cardiopulmonary impairment: The role of the microvascular damage 59
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 55
Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A “Real-Life” Observational Study 54
Eucapnic Voluntary Hyperpnea: Gold Standard for Diagnosing Exercise-Induced Bronchoconstriction in Athletes? 53
Mucins MUC5B and MUC5AC in distal airways and honeycomb spaces: Comparison among idiopathic pulmonary fibrosis/usual interstitial pneumonia, fibrotic nonspecific interstitial pneumonitis, and control lungs 46
European Respiratory Society guidelines for the diagnosis of asthma in adults 45
Real-world experience with benralizumab in patients with severe eosinophilic asthma: A case series 43
ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy 42
Exertional dyspnoea in interstitial lung diseases: The clinical utility of cardiopulmonary exercise testing 32
Totale 3.262
Categoria #
all - tutte 18.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 6 5 0 11 6 9 3
2021/2022242 4 2 5 15 9 1 3 31 15 31 36 90
2022/2023714 92 105 79 99 33 78 39 49 96 9 27 8
2023/2024340 12 90 5 53 9 31 17 11 3 24 39 46
2024/2025667 26 20 64 22 27 34 22 21 103 67 135 126
2025/20261.039 264 44 131 260 271 69 0 0 0 0 0 0
Totale 3.262